Dimensional Fund Advisors LP lowered its position in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 60.0% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,162 shares of the company's…
Continue reading...